Northside Capital Management LLC increased its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,335 shares of the pharmacy operator’s stock after buying an additional 184 shares during the quarter. Northside Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $570,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in WBA. Cornerstone Advisors Inc. boosted its position in Walgreens Boots Alliance by 102.4% in the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 214 shares during the last quarter. Moody National Bank Trust Division boosted its position in Walgreens Boots Alliance by 0.6% in the fourth quarter. Moody National Bank Trust Division now owns 90,878 shares of the pharmacy operator’s stock worth $6,209,000 after purchasing an additional 567 shares during the last quarter. IFG Advisory LLC boosted its position in Walgreens Boots Alliance by 13.9% in the third quarter. IFG Advisory LLC now owns 5,143 shares of the pharmacy operator’s stock worth $374,000 after purchasing an additional 627 shares during the last quarter. WoodTrust Financial Corp boosted its position in Walgreens Boots Alliance by 2.1% in the third quarter. WoodTrust Financial Corp now owns 31,178 shares of the pharmacy operator’s stock worth $2,273,000 after purchasing an additional 656 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV boosted its position in Walgreens Boots Alliance by 2.9% in the third quarter. Massmutual Trust Co. FSB ADV now owns 24,639 shares of the pharmacy operator’s stock worth $1,796,000 after purchasing an additional 695 shares during the last quarter. Institutional investors and hedge funds own 62.98% of the company’s stock.
Shares of NASDAQ WBA traded down $0.97 during trading on Monday, reaching $70.74. 2,667,990 shares of the stock traded hands, compared to its average volume of 6,014,670. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.80 and a quick ratio of 0.36. Walgreens Boots Alliance Inc has a 52-week low of $59.07 and a 52-week high of $86.31. The stock has a market capitalization of $68.15 billion, a PE ratio of 11.75, a P/E/G ratio of 1.13 and a beta of 0.99.
In related news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the business’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the sale, the executive vice president now directly owns 81,076 shares in the company, valued at approximately $6,386,356.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total value of $217,457.28. Following the sale, the director now owns 8,207 shares in the company, valued at $652,292.36. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 73,756 shares of company stock worth $5,824,194. 15.73% of the stock is currently owned by corporate insiders.
WBA has been the topic of several research analyst reports. Pivotal Research boosted their price objective on Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a research report on Monday, October 15th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Friday, November 30th. Goldman Sachs Group cut Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a research report on Friday, December 14th. Loop Capital upped their price target on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, October 12th. Finally, JPMorgan Chase & Co. upped their price target on Walgreens Boots Alliance from $83.00 to $91.00 and gave the company an “overweight” rating in a research report on Monday, October 8th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $79.35.
ILLEGAL ACTIVITY WARNING: “Northside Capital Management LLC Buys 184 Shares of Walgreens Boots Alliance Inc (WBA)” was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.com-unik.info/2019/01/14/northside-capital-management-llc-buys-184-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: Fundamental Analysis – How It Helps Investors
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.